Weight management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
Eli Lilly and Company |
Friday
Ildiko Lingvay (USA) 23.09.2022 08:15 – 08:25 VIRTUAL ONLY: Cori Hall
Is HFpEF hiding in your practice? An expert debate on the emerging role of diabetologists
PACE-CME funded by an unrestricted educational grant provided by AstraZeneca |
Friday
Chair: Silvio Inzucchi (USA) 08:00 – 08:05 Introduction Silvio Inzucchi (USA) 08:05 – 08:10 Update on new developments of HFpEF and diabetes Silvio Inzucchi (USA) 08:10 – 08:15 HFpEF and Diabetes: What are the clinical challenges? Pardeep Jhund (UK) 08:15 – 08:30 How does new evidence impact the need for identification and management of patients […]
CGM in the ADA / EASD Consensus Report and Eversense E3 CGM in clinical practice.
Ascensia Diabetes Care Holdings AG |
Thursday
18:30 – 18:50 CGM in ADA / EASD Consensus report. Use of Eversense in diabetes treatment. Tomasz Klupa (POL) 18:50 – 19:10 Eversense CGM System in clinical practice. Sergio Di Molfetta (ITA) 19:10 – 19:30 The new evolution of Eversense technology. Francine Kaufman (USA) 22.09.2022 18:30 – 19:30 Yalow Hall
How use of Smart MDI system is transforming MDI therapy: Perspectives from our R&D Clinical Expert
Medtronic International Trading Sàrl |
Tuesday
Chair: Anna-Rea Laubscher (CHE) 15:45 – 16:15 How use of Smart MDI system is transforming MDI therapy: Perspectives from our R&D Clinical Expert Madison Smith (USA) 20.09.2022 15:45 – 16:15 Networking Hub
Successful initiation of the MiniMed 780G system
Medtronic International Trading Sàrl |
Wednesday
11:45 – 11:55 Introducing the MiniMed 780G system Ohad Cohen (ISR) 11:55 – 12:15 Succesful initiation of the MiniMed 780G system: practical case Goran Petrovski (QAT) Chair: Ohad Cohen (ISR) 21.09.2022 11:45 – 12:15 Networking Hub
Weight management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
Eli Lilly and Company |
Wednesday
Ildiko Lingvay (USA) 21.09.2022 08:15 – 08:25 VIRTUAL ONLY: Cori Hall
Treatment simplification of complex insulin regimens to improve outcomes in T2D
Sanofi |
Thursday
13:00 – 13:30 Suliqua Meet the Expert Katie Whitmire (USA)Rory McCrimmon (USA) 22.09.2022 13:00 – 13:30 Networking Hub
Moving Beyond HbA1c with Time in Range
Abbott |
Wednesday
16:00 – 16:30 Moving Beyond HbA1c with Time in Range Key challenges with the gold standard HbA1c in diabetes management in the daily practice How can TIR empower my diabetes team in the daily practice? Kelly Close (USA) Thomas Danne (GER) 21.09.2022 16:00 – 16:30 Networking Hub
Understanding the importance of individualizing glycemic targets in Theory vs. Practice
Abbott |
Wednesday
Moderator: Kelly Close (USA) 13:00 – 13:30 Understanding the Importance of Individualizing Glycemic Targets in Theory vs. PracticeHow to individualize Time in Range goals of my patients – percentage or range or both? Tadej Battelino (SVN)Samuel Seidu (UK) 21.09.2022 13:00 – 13:30 Networking Hub
Podcast | Boehringer Ingelheim and Eli Lilly and Company
Kidney disease in the context of T2D management. Important facts you need to know! Listen to this short podcast where Professor Per-Henrik Groop and Professor Kamlesh Khunti provide you with the most important facts you need to know. …available on the EASD 2022 Virtual Meeting platform (for registered delegates)!
